LMAT on XNAS, Health Care, LeMaitre Vascular, Inc., job postings
Measures activity, not value. Not investment advice.
Revenue rose 11% but shares fell 25% in six months while short interest rose to 1.5 times last year.
BadInstitutional holders fell to 296 from 319 last quarter
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Industry
Surgical & medical instruments & apparatus (Health Care)
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $68.0M, net income $15.0M.
31 Dec 2021RevenueNet incometallest bar $70.4M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$68.0M
$15.0M
30 Jun 2026
$70.4M
$17.1M
31 Mar 2026
$66.6M
$15.7M
31 Dec 2025
–
$15.6M
30 Sep 2025
$61.0M
$17.4M
30 Jun 2025
$64.2M
$13.8M
31 Mar 2025
$59.9M
$11.0M
31 Dec 2024
$55.7M
$11.2M
30 Sep 2024
$54.8M
$11.1M
30 Jun 2024
$55.8M
$11.8M
31 Mar 2024
$53.5M
$9.9M
31 Dec 2023
$48.9M
$8.5M
30 Sep 2023
$47.4M
$7.5M
30 Jun 2023
$50.1M
$8.1M
31 Mar 2023
$47.1M
$6.0M
31 Dec 2022
$41.0M
$5.6M
30 Sep 2022
$39.0M
$5.5M
30 Jun 2022
$42.1M
$3.5M
31 Mar 2022
$39.6M
$6.0M
31 Dec 2021
$39.5M
$6.2M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$269.4M
$240.9M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+12%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$63.3M
$53.3M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$2.75
$2.31
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
72.0%
71.0%
60.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
27.7%
25.7%
-8.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
23.5%
22.1%
-10.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
15.6%
-26.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$67.0M
$66.2M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$389.7M
$343.1M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$169.3M
$168.4M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$220.4M (net cash)
-$174.6M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.39
0.31
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$18.89
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
26.6
28.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
6.3
2.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
5.4
2.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
3.9
2.8
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
1.1%
1.4%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
-7.2%
296 13F filers vs 319
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
23.9M shares held by 13F filers (30 Sep 2026) of 22.9M outstanding (2 Nov 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
7.2%
1.7M shares sold short (30 Oct 2026) of 22.9M outstanding (2 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
6.2
1.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-6.7%
1.8M shares sold short in the report before, 1.7M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
45%
45% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 65%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
21
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+11%
$68.0M vs $61.0M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+2.3%
$2.3M vs $2.3M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$202K
the 12 months before: $214K
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
17
17 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
17×
17 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Short interest 1.8M, 1.5× a year earlier
Price $73.61 on 20 Nov 2026, -13% over 12 months (12-month range $73.61 to $117.39)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $30.0M in the last 12 months (the 12 months before: -$21.1M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months.Revenue per quarter. Revenue $68.0M in the latest quarter, +11% on a year earlier.Capital spending per quarter. Capital spending $2.3M in the latest quarter, +2.3% on a year earlier.Institutional holders (13F filers). 296 13F filers reported holding it in the latest 13F quarter, +5.0% on a year earlier.Federal obligations. Federal obligations: $56K published in the last 12 months, -81% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $39.5M, +5.2% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $39.6M, +10% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $42.1M, +3.5% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $39.0M, +1.7% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $41.0M, +3.7% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $47.1M, +19% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $50.1M, +19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $47.4M, +21% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $48.9M, +19% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $53.5M, +14% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $55.8M, +11% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $54.8M, +16% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $55.7M, +14% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $59.9M, +12% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $64.2M, +15% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $61.0M, +11% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Mar 2026: $66.6M, +11% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $70.4M, +9.6% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $68.0M, +11% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $606K, -50% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $536K, -49% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $973K, -31% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $460K, -75% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $1.3M, +108% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $2.1M, +297% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $2.8M, +188% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.1M, +129% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.3M, +1.5% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $1.4M, -36% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $1.9M, -33% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $1.7M, +59% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $2.0M, +60% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $1.4M, +0.9% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $1.3M, -29% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $2.3M, +37% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $1.8M, -13% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $2.8M, +101% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $2.3M, +72% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $2.3M, +2.3% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 166; public on 14 Feb 2022
31 Mar 2022 report: 172; public on 16 May 2022
30 Jun 2022 report: 172; public on 15 Aug 2022
30 Sep 2022 report: 173; public on 14 Nov 2022
31 Dec 2022 report: 169; public on 14 Feb 2023
31 Mar 2023 report: 176; public on 15 May 2023
30 Jun 2023 report: 199; public on 14 Aug 2023
30 Sep 2023 report: 205; public on 14 Nov 2023
31 Dec 2023 report: 216; public on 14 Feb 2024
31 Mar 2024 report: 237; public on 15 May 2024
30 Jun 2024 report: 247; public on 14 Aug 2024
30 Sep 2024 report: 276; public on 14 Nov 2024
31 Dec 2024 report: 300; public on 14 Feb 2025
31 Mar 2025 report: 279; public on 15 May 2025
30 Jun 2025 report: 271; public on 14 Aug 2025
30 Sep 2025 report: 282; public on 14 Nov 2025
31 Dec 2025 report: 289; public on 17 Feb 2026
31 Mar 2026 report: 332; public on 15 May 2026
30 Jun 2026 report: 319; public on 14 Aug 2026
30 Sep 2026 report: 296; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $14K published
Month from 1 Jan 2022: $11K published
Month from 1 Apr 2022: $12K published
Month from 1 May 2022: -$2K published
Month from 1 Jun 2022: $43K published
Month from 1 Jul 2022: $23K published
Month from 1 Nov 2022: $13K published
Month from 1 Dec 2022: $12K published
Month from 1 Feb 2023: $24K published
Month from 1 Mar 2023: $28K published
Month from 1 Apr 2023: $53K published
Month from 1 May 2023: $0 published
Month from 1 Jun 2023: $25K published
Month from 1 Jul 2023: $24K published
Month from 1 Aug 2023: $28K published
Month from 1 Sep 2023: $11K published
Month from 1 Oct 2023: $56K published
Month from 1 Nov 2023: $13K published
Month from 1 Dec 2023: $27K published
Month from 1 Jan 2024: $45K published
Month from 1 Feb 2024: $32K published
Month from 1 May 2024: $133K published
Month from 1 Jun 2024: $37K published
Month from 1 Jul 2024: $11K published
Month from 1 Aug 2024: $22K published
Month from 1 Sep 2024: $27K published
Month from 1 Oct 2024: $11K published
Month from 1 Dec 2024: $14K published
Month from 1 Feb 2025: $27K published
Month from 1 Mar 2025: -$23K published
Month from 1 Apr 2025: $97K published
Month from 1 Jun 2025: $27K published
Month from 1 Jul 2025: $134 published
Month from 1 Aug 2025: $46K published
Month from 1 Sep 2025: $34K published
Month from 1 Oct 2025: $56K published
Month from 1 Nov 2025: $12K published
Month from 1 Mar 2026: $38K published
Month from 1 May 2026: $16K published
Month from 1 Jun 2026: $600 published
Month from 1 Aug 2026: $600 published
Month from 1 Nov 2026: $705 published
What is unusual now
Made public in the last 90 days: it had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year; it also had 1.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year. 3 sharp changes in all.
Short interest spike: had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year Public on 27 Oct 2026.
21 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 48%, Finance & accounting 24%, Software engineering 14%, Test, quality & reliability 10%.
Changes and notable records, by the date each became public
27 Oct 2026Short interest and volume change
had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year.
Same report last year: 1.2M; its normal report is 1.2M.
See the evidence
This period
1.8M (the 15 Oct 2026 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
73K
How far from its usual level
+4.5
Same report last year
1.2M
History used
3,212 days
the 15 Oct 2026 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year.
Same report last year: 1.2M; its normal report is 1.2M.
See the evidence
This period
1.7M (the 30 Sep 2026 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
69K
How far from its usual level
+4.2
Same report last year
1.2M
History used
3,197 days
the 30 Sep 2026 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.7M shares sold short in the 15 Sep 2026 report, 1.3× the same report last year.
Same report last year: 1.3M; its normal report is 1.2M.
See the evidence
This period
1.7M (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
64K
How far from its usual level
+3.8
Same report last year
1.3M
History used
3,182 days
the 15 Sep 2026 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 37 13F filers open a new position in the quarter ended 30 Sep 2025, 1.0× the same quarter last year.
Same quarter last year: 37; its normal quarter is 24.
See the evidence
This period
37 (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
24
Typical spread (median absolute deviation)
2.5
How far from its usual level
+3.5
Same quarter last year
37
History used
4,383 days
the quarter ended 30 Sep 20258 earlier quartersnormal: 24
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 1.3M shares sold short in the 31 Jan 2025 report, 1.4× the same report last year.
Same report last year: 920K; its normal report is 854K.
See the evidence
This period
1.3M (the 31 Jan 2025 report)
Normal report (median of 24 earlier)
854K
Typical spread (median absolute deviation)
76K
How far from its usual level
+4.0
Same report last year
920K
History used
2,590 days
the 31 Jan 2025 report24 earlier reportsnormal: 854K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.3M shares sold short in the 15 Jan 2025 report, 1.3× the same report last year.
Same report last year: 971K; its normal report is 854K.
See the evidence
This period
1.3M (the 15 Jan 2025 report)
Normal report (median of 24 earlier)
854K
Typical spread (median absolute deviation)
76K
How far from its usual level
+3.9
Same report last year
971K
History used
2,574 days
the 15 Jan 2025 report24 earlier reportsnormal: 854K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 35 13F filers open a new position in the quarter ended 31 Mar 2024, 2.7× the same quarter last year.
Same quarter last year: 13; its normal quarter is 21.5.
See the evidence
This period
35 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
21.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+3.6
Same quarter last year
13
History used
3,835 days
the quarter ended 31 Mar 20248 earlier quartersnormal: 21.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 920K shares sold short in the 31 Jan 2024 report, 2.0× the same report last year.
Same report last year: 455K; its normal report is 612K.
See the evidence
This period
920K (the 31 Jan 2024 report)
Normal report (median of 24 earlier)
612K
Typical spread (median absolute deviation)
55K
How far from its usual level
+3.8
Same report last year
455K
History used
2,224 days
the 31 Jan 2024 report24 earlier reportsnormal: 612K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 971K shares sold short in the 12 Jan 2024 report, 1.8× the same report last year.
Same report last year: 551K; its normal report is 609K.
See the evidence
This period
971K (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
609K
Typical spread (median absolute deviation)
46K
How far from its usual level
+5.3
Same report last year
551K
History used
2,205 days
the 12 Jan 2024 report24 earlier reportsnormal: 609K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 961K shares sold short in the 29 Dec 2023 report, 1.7× the same report last year.
Same report last year: 581K; its normal report is 608K.
See the evidence
This period
961K (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
608K
Typical spread (median absolute deviation)
32K
How far from its usual level
+5.8
Same report last year
581K
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 608K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 949K shares sold short in the 15 Dec 2023 report, 1.7× the same report last year.
Same report last year: 557K; its normal report is 608K.
See the evidence
This period
949K (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
608K
Typical spread (median absolute deviation)
32K
How far from its usual level
+5.6
Same report last year
557K
History used
2,177 days
the 15 Dec 2023 report24 earlier reportsnormal: 608K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 952K shares sold short in the 30 Nov 2023 report, 1.7× the same report last year.
Same report last year: 568K; its normal report is 600K.
See the evidence
This period
952K (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
600K
Typical spread (median absolute deviation)
24K
How far from its usual level
+5.9
Same report last year
568K
History used
2,162 days
the 30 Nov 2023 report24 earlier reportsnormal: 600K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.1M shares sold short in the 15 Nov 2023 report, 1.9× the same report last year.
Same report last year: 547K; its normal report is 587K.
See the evidence
This period
1.1M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
587K
Typical spread (median absolute deviation)
29K
How far from its usual level
+8.1
Same report last year
547K
History used
2,147 days
the 15 Nov 2023 report24 earlier reportsnormal: 587K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.2M shares sold short in the 31 Oct 2023 report, 1.5× the same report last year.
Same report last year: 806K; its normal report is 587K.
See the evidence
This period
1.2M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
587K
Typical spread (median absolute deviation)
29K
How far from its usual level
+10.4
Same report last year
806K
History used
2,132 days
the 31 Oct 2023 report24 earlier reportsnormal: 587K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 932K shares sold short in the 13 Oct 2023 report, 1.1× the same report last year.
Same report last year: 811K; its normal report is 587K.
See the evidence
This period
932K (the 13 Oct 2023 report)
Normal report (median of 24 earlier)
587K
Typical spread (median absolute deviation)
29K
How far from its usual level
+5.9
Same report last year
811K
History used
2,114 days
the 13 Oct 2023 report24 earlier reportsnormal: 587K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 41 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year.
Same quarter last year: 21; its normal quarter is 21.
See the evidence
This period
41 (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
21
Typical spread (median absolute deviation)
3
How far from its usual level
+4.5
Same quarter last year
21
History used
3,560 days
the quarter ended 30 Jun 20238 earlier quartersnormal: 21
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 37 13F filers open a new position in the quarter ended 31 Dec 2020, 1.4× the same quarter last year.
Same quarter last year: 26; its normal quarter is 14.5.
See the evidence
This period
37 (the quarter ended 31 Dec 2020)
Normal quarter (median of 8 earlier)
14.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+6.1
Same quarter last year
26
History used
2,649 days
the quarter ended 31 Dec 20208 earlier quartersnormal: 14.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Showing the newest 40 of 45 entries; narrow the window or the kind of data to see older ones.
Not listed: 299 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001158895
Ticker
LMAT
Domain
lemaitre.com
Employer name
LeMaitre Vascular, Inc. (1 unverified)
Hq location
MA|BURLINGTON|01803 (1 unverified)
Name
Bio Nova Holdings Pty Ltd, Bio Nova International Pty Ltd, LeMaitre Acquisition LLC, LeMaitre Cardial SAS and 9 more
Uei
JWGPQCB8NFQ5
Wikipedia
LeMaitre Vascular
DOL H-1B labor condition applications and PERM certifications46 data points13 Jan 2020 to 5 May 2025
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)129 records24 Feb 2016 to 5 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1126 data points31 Dec 2008 to 2 Nov 2026
SEC Form 4 insider transactions191 records, 616 data points12 Jan 2016 to 11 May 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards1362 data points1 Oct 2007 to 20 Nov 2026
Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026